United Therapeutics Corp (UTHR)
373.22
-3.58
(-0.95%)
USD |
NASDAQ |
Nov 05, 09:38
United Therapeutics Debt to Equity Ratio: 0.0656 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.0656 |
| June 30, 2024 | 0.0878 |
| March 31, 2024 | 0.1124 |
| December 31, 2023 | 0.117 |
| September 30, 2023 | 0.1401 |
| June 30, 2023 | 0.1478 |
| March 31, 2023 | 0.1562 |
| December 31, 2022 | 0.1668 |
| September 30, 2022 | 0.1754 |
| June 30, 2022 | 0.1853 |
| March 31, 2022 | 0.1916 |
| December 31, 2021 | 0.2021 |
| September 30, 2021 | 0.2089 |
| June 30, 2021 | 0.2198 |
| March 31, 2021 | 0.2322 |
| December 31, 2020 | 0.2356 |
| September 30, 2020 | 0.2437 |
| June 30, 2020 | 0.2586 |
| March 31, 2020 | 0.2713 |
| December 31, 2019 | 0.3057 |
| September 30, 2019 | 0.3682 |
| June 30, 2019 | 0.4091 |
| March 31, 2019 | 0.4491 |
| December 31, 2018 | 0.089 |
| September 30, 2018 | 0.0922 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.0967 |
| March 31, 2018 | 0.1047 |
| December 31, 2017 | 0.1179 |
| September 30, 2017 | 0.1197 |
| June 30, 2017 | 0.1393 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.0005 |
| March 31, 2016 | 0.0031 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.0203 |
| June 30, 2015 | 0.0306 |
| March 31, 2015 | 0.1036 |
| December 31, 2014 | 0.0999 |
| September 30, 2014 | 0.2395 |
| June 30, 2014 | 0.2995 |
| March 31, 2014 | 0.2129 |
| December 31, 2013 | 0.2166 |
| September 30, 2013 | 0.2165 |
| June 30, 2013 | 0.2306 |
| March 31, 2013 | 0.2391 |
| December 31, 2012 | 0.2524 |
| September 30, 2012 | 0.2577 |
| June 30, 2012 | 0.2682 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0656
Minimum
Sep 2024
0.3057
Maximum
Dec 2019
0.1862
Average
0.1885
Median
Debt to Equity Ratio Benchmarks
| Liquidia Corp | 0.00 |
| Pfizer Inc | 0.7831 |
| Tonix Pharmaceuticals Holding Corp | 0.2016 |
| Ardelyx Inc | 0.6362 |
| Entrada Therapeutics Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.123B |
| Total Liabilities (Quarterly) | 1.022B |
| Shareholders Equity (Quarterly) | 6.101B |
| Current Ratio | 4.580 |
| Net Debt Paydown Yield | 0.50% |